Antiseizure Medications May Harm Bone Health in Children
This study looked at how antiseizure medications (ASMs) affect bone health in children aged 5 to 15 who had just been diagnosed with epilepsy and had not yet started treatment.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
This study looked at how antiseizure medications (ASMs) affect bone health in children aged 5 to 15 who had just been diagnosed with epilepsy and had not yet started treatment.
Researchers studied the CELSR1 gene and its impact on brain development and function in seven individuals from five different families.
Researchers studied juvenile absence epilepsy (JAE) to understand how it affects the brain and cognitive abilities.
Researchers in Thailand studied a group of 191 infants diagnosed with Infantile Epileptic Spasms Syndrome (IESS) to understand the causes of this condition and how well the medication vigabatrin (VGB) works as a first treatment.
Researchers studied the long-term effects of vagus nerve stimulation (VNS) on people with Dravet syndrome, a severe form of epilepsy.
Researchers studied a group of 60 patients with epilepsy characterized by myoclonic-atonic seizures, a type of seizure that can cause sudden falls and loss of muscle control.
This study focused on understanding brain changes in older adults with late-onset unexplained epilepsy (LOUE), which is epilepsy that starts after age 55 without a clear cause.
This study looked at how effective targeted gene panel testing is for diagnosing epilepsy in children.
This study looked at how well the ketogenic diet works for children with GLUT1 deficiency syndrome (GLUT1DS), a genetic condition that can cause seizures and other neurological problems.